Patient-reported outcomes after 10-year follow-up of intensive, multifactorial treatment in individuals with screen-detected type 2 diabetes: the ADDITION-Europe trial.

MLA

Dalsgaard, E. M., et al. “Patient-Reported Outcomes after 10-Year Follow-up of Intensive, Multifactorial Treatment in Individuals with Screen-Detected Type 2 Diabetes: The ADDITION-Europe Trial.” Diabetic Medicine : A Journal of the British Diabetic Association, vol. 37, no. 9, Sept. 2020, pp. 1509–18. EBSCOhost, https://doi.org/10.1111/dme.14342.

APA

Dalsgaard, E.-M., Sandbaek, A., Griffin, S. J., Rutten, G. E. H. M., Khunti, K., Davies, M. J., Irving, G. J., Vos, R. C., Webb, D. R., Wareham, N. J., & Witte, D. R. (2020). Patient-reported outcomes after 10-year follow-up of intensive, multifactorial treatment in individuals with screen-detected type 2 diabetes: the ADDITION-Europe trial. Diabetic Medicine : A Journal of the British Diabetic Association, 37(9), 1509–1518. https://doi.org/10.1111/dme.14342

Chicago

Dalsgaard, E-M, A Sandbaek, S J Griffin, G E H M Rutten, K Khunti, M J Davies, G J Irving, et al. 2020. “Patient-Reported Outcomes after 10-Year Follow-up of Intensive, Multifactorial Treatment in Individuals with Screen-Detected Type 2 Diabetes: The ADDITION-Europe Trial.” Diabetic Medicine : A Journal of the British Diabetic Association 37 (9): 1509–18. doi:10.1111/dme.14342.